Paul Dye, MSEd
with Jer Weann Ang, Brian Curtis, Dheeraj Varandani, Bill Glass, Wesley Fisher and Anthony Lanza

University of Nebraska
Omaha, Nebraska, United States

Purpose
Demonstrated are the advantages of MDx-Chex® as a blood control through visualization of the product against other competitive products. The visualization shows each major blood component in the MDx-Chex control and the lack of similar components in others. MDx-Chex contains RBCs, WBC, platelets and other components. Competing products have components that do not match those found in patients. The comparison of the two products is vital to customers understanding their differences and the 3D visualization is vital to effectively communicating the differences they exhibit.

Equipment
ZBrush, Maya, Adobe Premiere, Adobe After Effects and Unity.